Stem Cell Therapeutics Receives U.S. Orphan Drug Designation

News   Nov 01, 2013

 
Stem Cell Therapeutics Receives U.S. Orphan Drug Designation
 
 
 
 

RELATED ARTICLES

Human Pluripotent Stem Cells Successfully 3D Printed

News

A breakthrough in the 3D-printing of human pluripotent stem cells means scientists are one step closer to being able to 3D print human organs and tissues for transplantation therapy.

READ MORE

Acquisition Sees Agilent Gain Powerful NGS IP Portfolio

News

Agilent Technologies announces its acquisition of the molecular and sample barcoding portfolios of Population Genetics Technologies.

READ MORE

Researchers Develop New Method to Generate Human Antibodies

News

Researchers hope their approach will help researchers rapidly generate therapeutic antibodies for the treatment of infectious diseases and other conditions such as cancer.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research Cell Science Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE